Skip to main content
. 2019 Jun 11;10:706. doi: 10.3389/fphys.2019.00706

Table 3.

Cardiometabolic risk marker values in SIT and WALK. Data are presented as median (minimum–maximum).

SIT WALK
Fasting glucose (mmol/L) 5.0 (3.9–6.2) 5.1 (3.8–5.9)
Fasting insulin (μU/mL) 7.7 (4.2–8.9) 7.3 (5.0–11.9)
Fasting TG (mmol/L) 0.8 (0.6–1.0) 0.8 (0.6–1.1)
tAUC glucose (mmol/L.5-h) 29.5 (23.4–34.2) 25.6 (18.5–38.1)
Net iAUC glucose (mmol/L.5-h) 3.2 (-5.7–13.0) 0.30 (-2.2–12.2)
Positive iAUC glucose (mmol/L.5-h) 3.2 (0.7–13.4) 2.0 (0.1–12.6)
tAUC insulin (μU/mL.5-h) 86.1 (174.5–421.6) 70.8 (113.0–294.7)
Net iAUC insulin (μU/mL.5-h) 82.6 (453.6–381.4) 65.9 (68.4–251.3)
Positive iAUC insulin (μU/mL.5-h) 82.6 (153.6–382.8) 59.5 (68.4–250.9)
tAUC TG (mmol/L.5-h) 1.0 (3.2–6.6) 1.2 (2.6–6.4)
Net iAUC TG (mmol/L.5-h) 0.8 (0.4–2.8) 0.5 (-0.3–1.6)
Positive iAUC TG (mmol/L.5-h) 1.1 (0.4–2.8) 0.7 (0.0–5.5)

significant difference between WALK and SIT (p < 0.01); SIT, uninterrupted sitting; WALK, breaking up sitting with walking; TG, triglycerides; tAUC, total area under the curve; iAUC, incremental area under the curve.